chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am a breastfeeding mom, I did have a strong immune response but that is not what I am reporting. My breast milk while I was sick with flu like symptoms from the vaccine changed to a chemical taste and it burnt my throat. I tasted it only because my baby was crying every time I was trying to feed her. The vile taste was in all of my breast milk while I was sick until my symptoms resolved 24 hours later. As I got better the taste was less noticeable. I wish I had kept the milk to be tested but ended up discarding all of it.
Pt broke out in generalized papular rash, up swelling, some labored breathing, and redness to face.
no problems for 2 days then devel t105-cried almost cont for 2 days;nl fussy type cry-did not see MD because incident occurred during snow;talked to MD x 4 or 5 times on phone
Client received 1st dose of Pfizer vaccine @ 11:47.  Around 1150, she stated feeling nauseated and needing to throw up. She was walked to the bathroom in accompany of 2 medical staff members. Vitals @ 11:57, O2-99, BP 138/74, Pulse 78. She returned to her seated family and remained under supervision until 12:17P
Patient reported having fever and chills the same day of vaccine. The next day she began to feel swelling near the injection site that traveled to underneath her right armpit. More side effects continued to include green bruising from the inner part of her underarm, all the way down to the right side of her upper lateral torso. Patient stated that she had once gotten surgery on that same arm years ago. Her husband also received the same vaccine with no unexpected side effects other than fever, chills and arm soreness. They both stated still feeling somewhat fatigued.
Child had a low fever from 04/24/02-04/25/02. High fever (103 deg F) on 04/26/02. Child had rash in upper thighs and diaper area. Child was given Tylenol for fever.
sore/swollen throat; sore/swollen throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore/swollen throat) and PHARYNGEAL SWELLING (sore/swollen throat) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore/swollen throat) (seriousness criterion medically significant) and PHARYNGEAL SWELLING (sore/swollen throat) (seriousness criterion medically significant). At the time of the report, OROPHARYNGEAL PAIN (sore/swollen throat) and PHARYNGEAL SWELLING (sore/swollen throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 16Mar2021 15:30 (Lot number: EL3247) at the age of 52 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ADVIL [IBUPROFEN]; EXCEDRIN [CAFFEINE; PARACETAMOL]; ALPRAZOLAM. Past drug history included: Xanax. Vaccination history included: Bnt162b2 (1st dose, Lot number=EL3247, time: 03:30 PM, Vaccine location: Right arm), administration date: 23Feb2021, when the patient was 52 years old, for Covid-19 immunisation. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 16Mar2021 15:30, outcome "recovered", described as "site injection pain"; GASTRIC DISORDER (non-serious) with onset 16Mar2021 15:30, outcome "recovered", described as "stomach issues"; FATIGUE (non-serious) with onset 17Mar2021, outcome "recovered", described as "extreme tiredness". Therapeutic measures were not taken as a result of vaccination site pain, gastric disorder, and fatigue. Additional information: The patient was also taking the following medication in two weeks: juice plus vitamin and allergy medication. The patient had no other vaccine in four weeks. The patient had no Covid-19 prior vaccination and was not Covid-19 tested post vaccination. The patient had no known allergies. No follow-up attempts are possible. No further information is expected.
Had miscarriage. Pregnancy was noted not to be progressing as it should be on March 4th, had repeat on March 12th which showed the pregnancy was not progressing and degenerating.  Had to take Cytotec on Monday March 15th.   After 2 f/u  had retained fetal tissue, had to take cytotec again - cannot remember exact date - then finally repeat  showed things had improved.
Worsening SOB; asthma worse w/in 30-60 min. After several hours, shortness of breath, not responding to albuterol inhaler - by 6:00 PM, SOB severe and told Mom.
Narrative:  No adverse reactions or outcomes. Pt had Moderna vaccine February 10,2021. He stated that he did not remember receiving that vaccine. Janssen vaccine was administered Jun 15, 2021. Pharmacy notified. He stated that he did not need to have any additional doses since he had a valid dose with the Janssen.
loss of taste /lost all taste; metallic taste in mouth/metal taste; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a male patient of an unspecified age received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8736), dose 1 via an unspecified route of administration on 28Apr2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 28Apr2021 patient experienced loss of taste /lost all taste, metallic taste in mouth/metal taste. (Withheld) received Pfizer Covid-19 vaccine first dose on 28Apr2021 and experienced side effects but he doesn't want to tell what kind of side effects. (Withheld) disconnected from the call and created a manual AE form. Caller has questions about side effects he is experiencing such as loss of taste and a metallic taste in mouth. He was speaking to someone prior to me, but call got disconnected. Declined isi. faxed ae. Cold transferred. Patient called about the Pfizer COVID Vaccine and states he has a question about the side effects of the vaccine; states 5 minutes after he had the 1st dose of the Pfizer COVID Vaccine he had a really strong metal taste and that is all he could taste and then he lost all taste and the taste progressively is going away; asks should he get a covid test and states he asked his HCP and the HCP has not yet called him back yet. Caller asked how long the report would take and declined to complete the report and requested transfer to and states if he has time after he speaks with he may do the report then. PC filed. Full report details not obtained due to caller declined to complete report; caller was provided the contact information for option #3; caller was placed on hold; due to larger than normal call volumes for, the caller agreed to be placed into the queue for the next available agent. Is there a Product Complaint: Yes. The outcome for the events was unknown.  No follow-up attempts are needed. No further information is expected.
Redness from elbow to shoulder all the way around arm; Swelling at injection site the size of quarter; Second week her arm  began itching; Second week her arm  began burning; Fisrt week she had little bump; First week she had redness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Fisrt week she had little bump), BURNING SENSATION (Second week her arm  began burning), ERYTHEMA (Redness from elbow to shoulder all the way around arm), INJECTION SITE ERYTHEMA (First week she had redness) and INJECTION SITE PRURITUS (Second week her arm  began itching) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE MASS (Fisrt week she had little bump) and INJECTION SITE ERYTHEMA (First week she had redness). On 28-Jan-2021, the patient experienced BURNING SENSATION (Second week her arm  began burning) and INJECTION SITE PRURITUS (Second week her arm  began itching). On 03-Feb-2021, the patient experienced ERYTHEMA (Redness from elbow to shoulder all the way around arm) and INJECTION SITE SWELLING (Swelling at injection site the size of quarter). At the time of the report, INJECTION SITE MASS (Fisrt week she had little bump), BURNING SENSATION (Second week her arm  began burning), ERYTHEMA (Redness from elbow to shoulder all the way around arm), INJECTION SITE ERYTHEMA (First week she had redness), INJECTION SITE PRURITUS (Second week her arm  began itching) and INJECTION SITE SWELLING (Swelling at injection site the size of quarter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Vitamins, Heart burn medication and Thyroid medication.  No treatment medications were reported.  The patient reported that everyday her condition progressed.
Daughter of patient states that mother has bloated stomach since last covid vaccination. Denies any pain, vomiting, blood in stool, tenderness, or hardening of stomach. Patient has hx of constipation. Patient has taken Beano and modified diet for alleviation of symptom with no effect.  An appointment with provider is scheduled on 3/23/21. Will follow up with patient on 3/24/21.
My son passed out shorty after receiving his 2 month vaccines. Seconds later he woke up, but was not the same child. He was very quiet and would share off. As days passed he was acting strange and could not extend his right arm. After muitiple visits to his pediatrician and specialist, he was diagnosed at 5 months with microcephaly. Till this day he is very delayed and It was because of those vaccines.
On approximately 09/27/2000, the patient developed a "light case of chickenpox with no fever". Unspecified medical attention was sought. Additional information has been requested.
root canal; excruciating headache; I'm in a lot of pain; muscle pain; excruciating joint pain all over; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (I'm in a lot of pain), ENDODONTIC PROCEDURE (root canal), MYALGIA (muscle pain), ARTHRALGIA (excruciating joint pain all over) and HEADACHE (excruciating headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced PAIN (I'm in a lot of pain), MYALGIA (muscle pain) and ARTHRALGIA (excruciating joint pain all over). On 11-Feb-2021, the patient experienced ENDODONTIC PROCEDURE (root canal) and HEADACHE (excruciating headache). At the time of the report, PAIN (I'm in a lot of pain), ENDODONTIC PROCEDURE (root canal), MYALGIA (muscle pain), ARTHRALGIA (excruciating joint pain all over) and HEADACHE (excruciating headache) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported.
reported feeling "foggy" immediately following vaccination about 10 mins. in observation lot.  told observer she was having tingling lips & had broken out in a rash with increased " foggy feeling".  seen at 11:35- full facial hives & neck & chest hives with associated felling of throat tightening & dysphagia.  Given 0.3ml EPI via auto injector R. thight.  EMS activated & pt. monitored.   no contributory medical history.  only med PRN zyrtec
I got the shot 8/22. On 8/25 I realized that the lymph nodes in my left armpit was tender, painful, hot to the touch, and swollen. The extreme tenderness went away however my left lymph node area (up to and including my chest and arm) are still enlarged and harder to the touch compared to the same area on the right side. Additionally, on 8/25 or 8/26 I awoke to find what looked like a burn (that developed internally) on my lympnode area, it was also tender to the touch. The burn later peeled and as of today it is fading but still visible. I also recently suffered from muscular pain in my left shoulder for 4-5 days. After taking an anti inflammatory (aleve) for 2 days, the shoulder pain subsided. The enlarged left area of my chest/lymph node still persists and feels tight/ hardened to the touch.
Patient received J&J Covid-19 vaccine on 4/9/21. Patient developed upper respiratory symptoms, fever, chills, nausea, vomiting, diarrhea, anorexia on 4/15/21. Patient tested positive for Covid-19 rapid test on 4/19/21. Patient presented to emergency department on 5/2 with continued symptoms. Patient found to be in acute renal failure with serum creatinine 23.7, BUN 179, and potassium 5.4. As of 5/7/21, patient's renal function has improved following daily hemodialysis and will be monitored for further renal recovery.
Pupura, easily bruising which turned out to be ITP (autoimmune disease) low platelets.
patient experienced extreme diarrhoea for a long time/she experienced diarrhea 4-5x; fever (low grade); This non-valid spontaneous report was received from an unspecified reporter via company representative referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were unknown.   On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot#, expiration date, route, dosing details were unknown) for prophylaxis.   On an unknown date, the patient experienced extreme diarrhea for a long time. The outcome of the event diarrhea was unknown.   The causal relationship between the suspect therapy and the event was not provided.  Follow-up was received on 23-OCT-2019 from the initial reporter, who was an  acupuncturist. Upon receive of follow up information, patient identifiers were provided and the case is now considered valid. This report refers to a 70-year-old female patient. No information regarding the patient's concurrent conditions and concomitant medications was provided. It was reported that the patient had a fever after vaccination with influenza virus vaccine (unspecified) when she was 63-year-old (approximately in 2012).  On 25-SEP-2019 at 11:00, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # S009945, expiration date 10-OCT-2021; route of administration, exact dose and frequency were not provided) for prophylaxis at a clinic. At the same time, the patient was vaccinated with influenza virus vaccine (unspecified) (lot # 3L32N, expiration date 30-JUN-2020; route of administration, exact dose, indication and frequency were not provided).  On 25-SEP-2019 at 22:30, after vaccination with the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and influenza virus vaccine (unspecified), the patient experienced diarrhea with intensity of 4-5 times without (w/o) cramp and she experienced fever (low grade). There was no treatment administered for the event. The patient drank a lot of warm water to recover from these events. The outcome of the events was reported as recovered/resolved on an unspecified date in 2019.  The relatedness between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), influenza virus vaccine (unspecified) and the events was not provided.  This is one of the two reports received from the same reporter.; Sender's Comments:  US-009507513-1910USA000369:
Erythema, swelling and pain of ears while playing outdoors in cold weather; this occurred same day after receiving her third HPV vaccine. Since then has also had additional episodes of cold urticaria with positive ice cube test.
DVT , Double thrombectomy  performed 11/28/2021 by Dr.
I am having severe itching on the injection side, burning and hot to the touch. I noticed my right ear is also turning red. My face is starting to itch also.
Lt upper arm - tenderness, redness, warmth noted 1MAR91 area 5" long, 3" wide nausea, 0 vomiting, weakness, fatigue, dizziness,temp. 3MAR91 ER dept Benadryl & Tylenol 4MAR91 dec red, dec swelling, itching all sx less today
an indent in my left upper arm, that appeared several weeks after I relieved the shot. Some tenderness to my left upper arm.  I also have discoloration in the center of the indent.
GERD; This spontaneous case was reported by an other health care professional and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (GERD) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031l20a) for COVID-19 prophylaxis.     It was unknown if the patient has ever been diagnosed with/tested positive for COVID-19. It was unknown if there was acute illnesses at the time of vaccination and up to one moth before.  Concurrent medical conditions included Allergy since 19-Dec-2019, Hyperlipidemia since 22-May-2018, Osteoporosis since 14-Mar-2019 and GERD since 22-Feb-2021. Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) from 14-Mar-2019 to an unknown date, ATORVASTATIN from 22-May-2018 to an unknown date, LORATADINE from 19-Dec-2019 to an unknown date, FAMOTIDINE from 22-Feb-2021 to an unknown date and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) from 19-Dec-2018 to an unknown date for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 22-Feb-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (GERD). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (GERD) outcome was unknown.      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received first dose at 14:09. Patient received second dose on 25-Feb-2021 at 10:58 am of 0.5 dose with lot number (006M20A) in left deltoid. Patient received third dose on 21-Dec-2021 at 11:56 am of 0.5 dose with lot number (078J21a) in right deltoid. Patient did not have any adverse event including signs symptoms, clinical course and or treatment with dates/timelines. No treatment information was provided.   This case was linked to MOD-2022-503571 (Patient Link).
Fully vaccinated, vaccine breakthrough disease.   Admitted for inpatient care on a telemetry unit
Information has been received from a nurse concerning an approximately 28 year old male who on 11-SEP-2006, at around 17:00 p.m., was vaccinated subdermally with a 0.5 mL dose of MMR. It was reported that the licensed practical nurse who administered the vaccine "was thinking TB" instead of subcutaneous. Localized redness was noted at the time and a bump where injected. No other symptoms were noted. The patient was referred from the clinic to the emergency room, however the patient went home. Patient contact information was not available and the clinic was unable to follow up with him at home.
Shortly after she experienced injection pain, swelling and redness. She claims to present with these symptoms and visited our pharmacy. She was advised to take OTC Benadryl. The arm did not improve so she went to urgent care. She was advised to go to the ER with cellulitis. She was given IV antibiotics and discharged with oral antibiotics
Information has been received from a medical assistant concerning a 9 weeks female patient with no known drug allergies and no pertinent medical history, who on 06-JUL-2009 was vaccinated orally with a dose of ROTATEQ.  Concomitant therapy included PENTACEL and PREVNAR which were administered on the same day.  There was no other concomitant therapy.  According to the reporter, on 06-JUL-2009 the patient experienced vomiting and diarrhea after administration of ROTATEQ.  The patient was examined in the emergency room but was not admitted.  At the time of the reporting the patient had recovered.  An ultrasound was performed (not results provided).  Additional information has been requested.
Red swollen area, warm to touch, white circle around area, hard knot, TYLENOL, cold compress.
This is a prospective pregnancy case. This 26-year-old female subject was enrolled in a study. The subject received dtpa vaccine (intramuscular) .5 ml on 22nd May 2014. The subject's past medical history included spontaneous abortion. The subject's last menstrual period was on 2nd November 2013 and estimated date of delivery was 9th August 2014. The subject received dtpa vaccine at week 28 of the pregnancy and during the third trimester of pregnancy. On 22nd May 2014, an unknown time after receiving dtpa vaccine the subject developed vaccine exposure during pregnancy (Non-serious). Additional event(s) included live birth. The outcome of vaccine exposure during pregnancy was unknown. The outcome(s) of the additional event(s) included live birth (unknown). The pregnancy resulted in a live neonate with apparent congenital anomaly. On 8th August 2014 after 39 weeks and 6 days, the subject gave birth to a male neonate via vaginal delivery. The neonate weighed 2024 grams (4lbs 7oz) at birth. APGAR scores were 8 and 9. It was unknown if the investigator considered the vaccine exposure during pregnancy and live birth to be related to dtpa vaccine.
Received a Moderna vaccine in error at age 17; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received a Moderna vaccine in error at age 17) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received a Moderna vaccine in error at age 17). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received a Moderna vaccine in error at age 17) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  It was reported that the parent never gave patient an additional dose.   Treatment information was not provided by the reporter.
Wednesday (day1)-fever 103.0, muscle and joint pain, fatigue, dizziness, headache Thursday (day2)- chills, muscle and joint pain, fatigue Friday (day3)- muscle and joint pain, fatigue Saturday (day4) muscle and joint pain, fatigue Sunday (day 5)- muscle and joint pain, fatigue, headache Monday (day6)- back pain, headache, fatigue